Skip to main content

Adamis Pharmaceuticals Corporation (ADMP)

NASDAQ: ADMP · IEX Real-Time Price · USD
0.715
0.002 (0.28%)
At close: Dec 8, 2021 4:00 PM
0.716
0.000 (0.042%)
After-hours:Dec 8, 2021 7:43 PM EST
Market Cap106.50M
Revenue (ttm)12.52M
Net Income (ttm)-57.42M
Shares Out148.89M
EPS (ttm)-0.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume974,702
Open0.720
Previous Close0.713
Day's Range0.710 - 0.735
52-Week Range0.480 - 2.340
Beta1.31
AnalystsBuy
Price Target1.00 (+39.8%)
Earnings Daten/a

About ADMP

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candida...

IndustryPharmaceuticals
CEODennis Carlo
Employees116
Stock ExchangeNASDAQ
Ticker SymbolADMP
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for ADMP stock is "Buy." The 12-month stock price forecast is 1.00, which is an increase of 39.80% from the latest price.

Price Target
$1.00
(39.80% upside)
Analyst Consensus: Buy

News

Top Penny Stocks For Your Under $1 List Right Now

Check these Under $1 penny stocks out for your watchlist The post Top Penny Stocks For Your Under $1 List Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:AGRXBRQS
1 week ago - PennyStocks

Adamis Pharmaceuticals Updates Comparative Pharmacology Model Data Supporting the Higher 5 mg Intramuscular Dose of N...

Drug overdoses are the leading cause of death for those under age 50 Drug overdoses are the leading cause of death for those under age 50

1 week ago - GlobeNewsWire

Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing Requirements

SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose...

2 weeks ago - GlobeNewsWire

Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET

2 weeks ago - GlobeNewsWire

Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business Update

SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose...

2 weeks ago - GlobeNewsWire

Top Penny Stocks to Watch Making Big Moves Right Now

If you're making a penny stocks watchlist right now, check these three small-caps out The post Top Penny Stocks to Watch Making Big Moves Right Now appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols:AGRXDNN
1 month ago - PennyStocks

ADMP Stock: The FDA News That Has Penny Stock Adamis Pharmaceuticals Rocketing Today

Adamis Pharmaceuticals (ADMP) stock is getting a major boost on Monday thanks to a response from the U.S. Food and Drug Administration. The post ADMP Stock: The FDA News That Has Penny Stock Adamis Phar...

1 month ago - InvestorPlace

Penny Stocks To Watch Today As Buying Drives ADMP, IO, LPCN & Others

A jump in penny stock prices has retail traders cashing out on big gains. The post Penny Stocks To Watch Today As Buying Drives ADMP, IO, LPCN & Others appeared first on Penny Stocks to Buy, Picks, News...

Other symbols:FAMIIOLPCNPROG
1 month ago - PennyStocks

Adamis Receives FDA Approval for ZIMHI

New High-Dose Naloxone Product for the Treatment of Opioid Overdose New High-Dose Naloxone Product for the Treatment of Opioid Overdose

1 month ago - GlobeNewsWire

Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors

Appointment of New Director with Significant Experience in Drug Development, Licensing and Commercialization Appointment of New Director with Significant Experience in Drug Development, Licensing and Co...

2 months ago - GlobeNewsWire

Adamis (ADMP) Begins Dosing in COVID Oral Antiviral Study

Adamis (ADMP) starts dosing patients in phase II/III study to evaluate its oral investigational antiviral for the treatment of COVID-19.

3 months ago - Zacks Investment Research

Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) has initiated dosing in the Phase 2/3 trial for Tempol, an oral antiviral product candidate, in adult patients with confirmed COVID-19 infection.  The t...

3 months ago - Benzinga

Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment of COVID-19

SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the initiation of patient dosing in the Phase 2/3 clinical trial for Tempol, an oral antiv...

3 months ago - GlobeNewsWire

Top Penny Stocks to Watch To Stay Ahead in September 2021

Which penny stocks are on your September watchlist? The post Top Penny Stocks to Watch To Stay Ahead in September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:JFINNAOV
3 months ago - PennyStocks

Trending Reddit Penny Stocks You Need to Know About Now

Reddit penny stocks are in focus following the meme stock rally; here's 3 to watch The post Trending Reddit Penny Stocks You Need to Know About Now appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols:EDURIG
3 months ago - PennyStocks

Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events

SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company's Chief Accounting Officer, wi...

3 months ago - GlobeNewsWire

Adamis Pharmaceuticals Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Temp...

Tempol: A potential home treatment for COVID-19 ( https://covid19.nih.gov/news-and-stories/tempol-potential-home-treatment-covid-19 ). Trial to begin shortly.

3 months ago - GlobeNewsWire

Adamis Highlights National Institutes of Health (NIH) Article Entitled, “Tempol: A Potential Home Treatment for COVID...

NIH Researchers Contend that Tempol can be taken orally and may stop the replication of the virus that causes COVID-19 NIH Researchers Contend that Tempol can be taken orally and may stop the replicatio...

3 months ago - GlobeNewsWire

Adamis Announces Agreement to Sell Portion of US Compounding Business

Transaction Proceeds Will be Used for General Corporate Purposes and Funding Intended Acceleration of Pharmaceutical Pipeline Transaction Proceeds Will be Used for General Corporate Purposes and Funding...

4 months ago - GlobeNewsWire

Adamis Announces Results of 2021 Annual Meeting of Stockholders

SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis” or the “Company”) today announced that based on the Inspector of Election's certified results from the Company's 2...

4 months ago - Business Wire

Adamis Urges Stockholders to Vote to Reelect the Company's Board of Directors at Upcoming Annual Meeting on Friday, J...

SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis” or the “Company”) today urged its valued stockholders to vote to reelect all five members of the Company's Board o...

4 months ago - Business Wire

Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist

Are these the best biotech penny stocks to watch right now? The post Best Biotech Penny Stocks In Summer 2021?

Other symbols:ACSTAMPEBIOLJAGXNWBO
5 months ago - PennyStocks

Adamis Sends Letter to Stockholders to Address Jerald A. Hammann's Costly, Distracting and Misguided Campaign

SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today issued the below letter to stockholders. *** July 1, 2021 Dear Stockholders, The Board of Directors (the "Board") appr...

5 months ago - Business Wire

Adamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COV...

SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today issued the below letter to stockholders. June 28, 2021 Dear Stockholder, The Board of Directors (the "Board") apprecia...

5 months ago - Business Wire

Are Options Traders Betting on a Big Move in Adamis Pharmaceuticals (ADMP) Stock?

Investors need to pay close attention to Adamis Pharmaceuticals (ADMP) stock based on the movements in the options market lately.

5 months ago - Zacks Investment Research